Download PDF
Z Gastroenterol 2011; 49(2): 294-303
DOI: 10.1055/s-0029-1245932
Mitteilungen

© Georg Thieme Verlag KG Stuttgart · New York

Empfehlungen zur Therapie der chronischen Obstipation der Arbeitsgruppe für Funktionsdiagnostik und Psychosomatik der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie

Recommendations on Therapy for Chronic Constipation – Working Group for Functional Diagnosis and Psychosomatics of the Austrian Society of Gastroenterology and HepatologyH. Vogelsang1 , J. Pfeiffer2 , G. Moser1
  • 1Abt. Gastroenterologie und Hepatologie, Univ.Klinik für Innere Medizin III, Medizinische Universität Wien
  • 2Klin. Abt. f. Allgemeinchirurgie, Medizinische Universität Graz
Further Information

Publication History

Manuskript eingetroffen: 30.8.2009

Manuskript akzeptiert: 21.11.2010

Publication Date:
04 February 2011 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Obstipation ist eines der häufigsten gastroenterologischen Probleme, insbesondere im höheren Alter. Die chronische Obstipation wird nun über die Rom-III-Kriterien definiert. Lebensstilmaßnahmen helfen meist nur im frühen Stadium bzw. bei eher leichten Ausprägungen. Bei Obstipation ist auf eine mögliche ursächliche Arzneimittelnebenwirkung zu achten, bei Opioiden stehen neuerdings wirksame Antagonisten bei Obstipation zur Verfügung. Bei Versagen dieser Maßnahmen sind medikamentös Polyethylenglykol oder Laktulose langfristig zu bevorzugen. Psychodiagnostische Fragen zur Angst sollten zur Diagnostik herangezogen werden. Biofeedback ist dann eine effektive Therapie in dieser Situation und insbesondere bei Beckenbodendyssynergie. Chirurgische Interventionen sind selten indiziert bzw. erfolgreich, außer bei Beckenbodenauslassstörungen mit schweren anatomischen Veränderungen.

Abstract

Constipation is one of the most frequent gastroenterological problems, especially among elderly people. Chronic constipation is now defined by the new Rome III criteria. Life style counselling is usually only effective in early stages of disease and for mild types. In patients with constipation one should actively screen for possible causative, medically adverse events. Recently new effective opioid antagonists were introduced to act against constipation in patients on long-term opioid therapy. If these actions fail, medical therapy with polyethylene glycol or lactulose should be favoured in the long-term treatment. Psychodiagnostic queries concerning fear should be included in the diagnostic procedures. Biofeedback is an effective therapy in these cases and especially with pelvic floor dyssynergia. Surgical interventions are rarely indicated or successful with the exception of chronic outlet obstruction with severe anatomic changes.

Schlüsselwörter

Obstipation - opoidinduziert - PEG - Psychologie - Chirurgie

Key words

constipation - opoid-induced - PEG - psychology - surgery

Literatur

  • 1 Johanson J F, Sonnenberg A, Koch T R. Clinical epidemiology of chronic constipation.  J Clin Gastroenterol. 1989;  11 (5) 525-536
    Google Scholar
  • 2 Stewart W F, Liberman J N, Sandler R S et al. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features.  Am J Gastroenterol. 1999;  9412) 3530-3540
    Google Scholar
  • 3 Talley N J, Weaver A L, Zinsmeister A R et al. Functional constipation and outlet delay: a population-based study.  Gastroenterology. 1993;  105 (3) 781-90
    Google Scholar
  • 4 Higgins P D, Johanson J F. Epidemiology of constipation in North America: a systematic review.  Am J Gastroenterol. 2004;  99 (4) 750-759
    Google Scholar
  • 5 Talley N J, Fleming K C, Evans J M et al. Constipation in an elderly community: a study of prevalence and potential risk factors.  Am J Gastroenterol. 1996;  91 (1) 19-25
    Google Scholar
  • 6 Longstreth G F. Functional bowel disorders.  Gastroenterology. 2006;  130 1480-1491
    Google Scholar
  • 7 Towers A L, Burgio K L, Locher J L et al. Constipation in the elderly: influence of dietary, psychological, and physiological factors.  J Am Geriatr Soc. 1994;  42 (7) 701-706
    Google Scholar
  • 8 Müller-Lissner S A. Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta-analysis.  Br Med J. 1988;  296 (6622) 615-617
    Google Scholar
  • 9 Badiali D, Corazziari E, Habib F I et al. Effect of wheat bran in treatment of chronic nonorganic constipation. A double-blind controlled trial.  Dig Dis Sci. 1995;  40 (2) 349-356
    Google Scholar
  • 10 Leung F W. Etiologic factors of chronic constipation: review of the scientific evidence.  Dig Dis Sci. 2007;  52 (2) 313-316
    Google Scholar
  • 11 Müller-Lissner S A, Kamm M A, Scarpignato C et al. Myths and misconceptions about chronic constipation.  Am J Gastroenterol. 2005;  100 (1) 232-242
    Google Scholar
  • 12 Bassotti G, Germani U, Fiorella S et al. Intact colonic motor response to sudden awakening from sleep in patients with chronic idiopathic (slow-transit) constipation.  Dis Colon Rectum. 1998;  41 (12) 1550-1555
    Google Scholar
  • 13 Kinnunen O. Study of constipation in a geriatric hospital, day hospital, old people’s home and at home.  Aging. 1991;  3 (2) 161-170
    Google Scholar
  • 14 Karam S E, Nies D M. Student/staff collaboration: a pilot bowel management program.  Gerontol Nurs. 1994;  20 (3) 32-40
    Google Scholar
  • 15 Meshkinpour H, Selod S, Movahedi H et al. Effects of regular exercise in management of chronic idiopathic constipation.  Dig Dis Sci. 1998;  43 (11) 2379-2383
    Google Scholar
  • 16 Ernst E. Abdominal massage therapy for chronic constipation: A systematic review of controlled clinical trials.  Forsch Komplementarmed. 1999;  6 (3) 149-151 Review
    Google Scholar
  • 17 Lämås K, Lindholm L, Stenlund H et al. Effects of abdominal massage in management of constipation – a randomized controlled trial.  Int J Nurs Stud. 2009;  46 (6) 759-767
    Google Scholar
  • 18 Dijk K N, Vries de C S, Berg van den P B et al. Constipation as an adverse effect of drug use in nursing home patients: an overestimated risk.  Br J Clin Pharmacol. 1998;  46 (3) 255-261
    Google Scholar
  • 19 McNicol E D, Boyce van D, Schumann R et al. Mu-opioid antagonists for opioid-induced bowel dysfunction.  Cochrane Database Syst Rev. 2008;  April 16 (2) CD006332 Review
    Google Scholar
  • 20 Webster L, Jansen J P, Peppin J et al. Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized,double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain.  Pain. 2008;  137 (2) 428-440
    Google Scholar
  • 21 Portenoy R K, Thomas J, Moehl Boatwright M L et al. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.  J Pain Symptom Manage. 2008;  35 (5) 458-468
    Google Scholar
  • 22 McNicol E, Boyce D B, Schumann R et al. Efficacy and safety of mu-opioid antagonists in the treatment of opioid-induced bowel dysfunction: systematic review and meta-analysis of randomized controlled trials.  Pain Med. 2008;  9 (6) 634-659 Review
    Google Scholar
  • 23 Simpson K, Leyendecker P, Hopp M et al. Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain.  Curr Med Res Opin. 2008;  24 (12) 3503-3512
    Google Scholar
  • 24 Löwenstein O, Leyendecker P, Hopp M et al. Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial.  Expert Opin Pharmacother. 2009;  10 (4) 531-543
    Google Scholar
  • 25 Meissner W, Leyendecker P, Mueller-Lissner S et al. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.  Eur J Pain. 2009;  13 (1) 56-64
    Google Scholar
  • 26 Herzog D B, Greenwood D N, Dorer D J et al. Mortality in eating disorders: a descriptive study.  Int J Eat Disord. 2000;  28 (1) 20-26
    Google Scholar
  • 27 Ramkumar D, Rao S S. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review.  Am J Gastroenterol. 2005;  100 (4) 936-971
    Google Scholar
  • 28 Thomson M A, Jenkins H R, Bisset W M et al. Polyethylene glycol 3350 plus electrolytes for chronic constipation in children: a double blind, placebo controlled, crossover study.  Arch Dis Child. 2007;  92 (11) 996-1000
    Google Scholar
  • 29 Di Palma J A, Cleveland M V, McGowan J et al. A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation.  Am J Gastroenterol. 2007;  102 (9) 1964-1971
    Google Scholar
  • 30 Attar A, Lemann M, Ferguson A et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation.  Gut. 1999;  44 (2) 226-230
    Google Scholar
  • 31 Voskuijl W, Lorijn de F, Verwijs W et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial.  Gut. 2004;  53 (11) 1590-1594
    Google Scholar
  • 32 Candy D C, Edwards D, Geraint M. Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy.  J Pediatr Gastroenterol Nutr. 2006;  43 (1) 65-70
    Google Scholar
  • 33 Ramkumar D, Rao S S. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review.  Am J Gastroenterol. 2005;  100 (4) 936-971
    Google Scholar
  • 34 Dupont C, Leluyer B, Maamri N et al. Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children.  J Pediatr Gastroenterol Nutr. 2005;  41 (5) 625-633
    Google Scholar
  • 35 Lederle F A, Busch D L, Mattox K M et al. Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose.  Am J Med. 1990;  89 (5) 597-601
    Google Scholar
  • 36 Kinnunen O, Salokannel J. Constipation in elderly long-stay patients: its treatment by magnesium hydroxide and bulk-laxative.  Ann Clin Res. 1987;  19 (5) 321-323
    Google Scholar
  • 37 Kienzle-Horn S, Vix J M, Schuijt C et al. Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study.  Aliment Pharmacol Ther. 2006;  23 (10) 1479-1488
    Google Scholar
  • 38 Manabe N, Cremonini F, Camilleri M et al. Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers.  Aliment Pharmacol Ther. 2009;  30 (9) 930-936
    Google Scholar
  • 39 Kinnunen O, Winblad I, Koistinen P et al. Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients.  Pharmacology. 1993;  47 (Suppl 1) 253-255
    Google Scholar
  • 40 Passmore A P, Wilson-Davies K, Stoker C et al. Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination.  BMJ. 1993;  307 (6907) 769-771
    Google Scholar
  • 41 Connolly P, Hughes I W, Ryan G. Comparison of „Duphalac” and „irritant” laxatives during and after treatment of chronic constipation: a preliminary study.  Curr Med Res Opin. 1974 / 1975;  2 (10) 620-625
    Google Scholar
  • 42 Müller-Lissner S, Kamm M A, Wald A et al. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation.  Am J Gastroenterol. 2010;  105 (4) 897-903
    Google Scholar
  • 43 Hamilton J W, Wagner J, Burdick B B et al. Clinical evaluation of methylcellulose as a bulk laxative.  Dig Dis Sci. 1988;  33 (8) 993-998
    Google Scholar
  • 44 Cheskin L J, Kamal N, Crowell M D et al. Mechanisms of constipation in older persons and effects of fiber compared with placebo.  J Am Geriatr Soc. 1995;  43 (6) 666-669
    Google Scholar
  • 45 Ashraf W, Park F, Lof J et al. Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation.  Aliment Pharmacol Ther. 1995;  9 (6) 639-647
    Google Scholar
  • 46 Odes H S, Madar Z. A double-blind trial of a celandin, aloevera and psyllium laxative preparation in adult patients with constipation.  Digestion. 1991;  49 (2) 65-71
    Google Scholar
  • 47 McRorie J W, Daggy B P, Morel J G et al. Psyllium is superior to docusate sodium for treatment of chronic constipation.  Aliment Pharmacol Ther. 1998;  12 (5) 491-497
    Google Scholar
  • 48 Tack J, Müller-Lissner S, Bytzer P et al. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.  Gut. 2005;  54 (12) 1707-1713
    Google Scholar
  • 49 Kale-Pradhan P B, Wilhelm S M. Tegaserod for constipation-predominant irritable bowel syndrome.  Pharmacotherapy. 2007;  27 (2) 267-277
    Google Scholar
  • 50 Harish K, Hazeena K, Thomas V et al. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.  J Gastroenterol Hepatol. 2007;  22 (8) 1183-1189
    Google Scholar
  • 51 Camilleri M, Kerstens R, Rykx A et al. A placebo-controlled trial of prucalopride for severe chronic constipation.  N Engl J Med. 2008;  358 (22) 2344-2354
    Google Scholar
  • 52 Tack J, Outryve van M, Beyens G et al. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.  Gut. 2009;  58 (3) 357-365
    Google Scholar
  • 53 Quigley E M, Vandeplassche L, Kerstens R et al. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12-week, randomized, double-blind, placebo-controlled study.  Aliment Pharmacol Ther. 2009;  29 (3) 315-328
    Google Scholar
  • 54 Johanson J F, Morton D, Geenen J et al. Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Lubiprostone, a Locally-Acting Type-2 Chloride Channel Activator, in Patients With Chronic Constipation.  Am J Gastroenterol. 2008;  103 (1) 170-177
    Google Scholar
  • 55 Johanson J F, Ueno R. Lubiprostone, a locally acting chloride channel activator, in adult patients withchronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety.  Aliment Pharmacol Ther. 2007;  25 (11) 1351-1361
    Google Scholar
  • 56 Drossman D A, Chey W D, Johanson J F et al. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome – results of two randomized, placebo-controlled studies.  Aliment Pharmacol Ther. 2009;  29 (3) 329-341
    Google Scholar
  • 57 Verne G N, Davis R H, Robinson M E et al. Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial.  Am J Gastroenterol. 2003;  98 (5) 1112-1116
    Google Scholar
  • 58 Soffer E E, Metcalf A, Launspach J. Misoprostol is effective treatment for patients with severe chronic constipation.  Dig Dis Sci. 1994;  39 (5) 929-933
    Google Scholar
  • 59 Bekkali N, Bongers M E, Van den Berg M M et al. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study.  Nutr J. 2007;  6 (1) 17
    Google Scholar
  • 60 Möllenbrink M, Bruckschen E. Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor).  Med Klin. 1994;  89 (11) 587-593
    Google Scholar
  • 61 Yang Y X, He M, Hu G et al. Effect of a fermented milk containing Bifidobacterium lactis DN-173 010 on Chinese constipatedwomen.  World J Gastroenterol. 2008;  14 (40) 6237-6243
    Google Scholar
  • 62 Merger M, Klebl F, Hierlmeier F X et al. Giant fecaliths in habitual constipation.  Dtsch Med Wochenschr. 1999;  124 (42) 1235-1238
    Google Scholar
  • 63 Chen C C, Su M Y, Tung S Y et al. Evaluation of polyethylene glycol plus electrolytes in the treatment of severe constipation and faecal impaction in adults.  Curr Med Res Opin. 2005;  21 (10) 1595-1602
    Google Scholar
  • 64 Sonnenberg A, Koch T R. Epidemiology of constipation in the United States.  Dis Colon Rectum. 1989;  32 1-8
    Google Scholar
  • 65 Mason H J, Serrano-Ikkos E, Kamm M A. Psychological morbidity in women with idiopathic constipation.  Am J Gastroenterol. 2000;  95 (10) 2852-2857
    Google Scholar
  • 66 Cheng C, Chan A O, Hui W M et al. Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: a population-based study.  Aliment Pharmacol Ther. 2003;  18 (3) 319-326
    Google Scholar
  • 67 Nehra V, Bruce B K, Rath-Harvey D M et al. Psychological disorders in patients with evacuation disorders and constipation in a tertiary practice.  Am J Gastroenterol. 2000;  95 (7) 1755-1758
    Google Scholar
  • 68 Dykes S, Smilgin-Humphreys S, Bass C. Chronic idiopathic constipation: a psychological enquiry.  Eur J Gastroenterol Hepatol. 2001;  13 (1) 39-44
    Google Scholar
  • 69 Chattat R, Bazzocchi G, Balloni M et al. Illness behavior, affective disturbance and intestnal transit time in idiopathic constipation.  J Psychosom Res. 1997;  42 95-100
    Google Scholar
  • 70 Wald A, Hinds J P, Caruana B J. Psychological and physiological characteristics of patients with severe idiopathic constipation.  Gastroenterology. 1989;  97 932-937
    Google Scholar
  • 71 Wald A, Burgio K, Holeva K et al. Psychological evaluation of patients with severe idiopathic constipation: which instrument to use.  Am J Gastroenterol. 1992;  87 (8) 977-980
    Google Scholar
  • 72 Grotz R L, Pemberton J H, Talley N J et al. Discriminant value of psychological distress, symptom profiles, and segmental colonic dysfunction in outpatients with severe idiopathic constipation.  Gut. 1994;  35 798-802
    Google Scholar
  • 73 Leroi A M, Berkelmans I, Denis P et al. Anismus as a marker of sexual abuse. Consequences of abuse on anorectal motility.  Dig Dis Sci. 1995;  40 1411-1416
    Google Scholar
  • 74 Garvey M, Noyes R Jr, Yates W. Frequency of constipation in major depression: relationship to other clinical variables.  Psychosomatics. 1990;  31 204-206
    Google Scholar
  • 75 Chun A B, Sokol M S, Kaye W H et al. Colonic and anorectal function in constipated patients with anorexia nervosa.  Am J Gastroenterol. 1997;  92 1879-1883
    Google Scholar
  • 76 Ashraf W, Park F, Lof J et al. An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation.  Am J Gastroenterol. 1996;  91 26-32
    Google Scholar
  • 77 Gorard D A, Gomborone J E, Libby G W et al. Intestinal transit in anxiety and depression.  Gut. 1996;  39 551-555
    Google Scholar
  • 78 Klauser A G, Voderholzer W A, Heinrich C A et al. Behavioral modification of colonic function. Can constipation be learned?.  Dig Dis Sci. 1990;  35 1271-1275
    Google Scholar
  • 79 Drossman D. Rom III – The functional gastrointestinal disorders. Degnon Associates; 2006 3 rd Ed: 510
    Google Scholar
  • 80 Whitehead W E, Chaussade S, Corrazziari E et al. Report of an international workshop on management of constipation.  Gastroenterology International. 1991;  4 99-113
    Google Scholar
  • 81 Emmanuel A V, Kamm M A. Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation.  Gut. 2001;  49 (2) 214-219
    Google Scholar
  • 82 Palsson O S, Heymen S, Whitehead W E. Biofeedback treatment for functional anorectal disorders: a comprehensive efficacy review.  Appl Psychophysiol Biofeedback. 2004;  29 (3) 153-174
    Google Scholar
  • 83 Chiarioni G, Whitehead W E, Pezza V et al. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia.  Gastroenterology. 2006;  130 (3) 657-664
    Google Scholar
  • 84 Mason H J, Serrano-Ikkos E, Kamm M A. Psychological state and quality of life in patients having behavioral treatment (biofeedback) for intractable constipation.  Am J Gastroenterol. 2002;  97 (12) 3154-3159
    Google Scholar
  • 85 Chiarioni G, Salandini L, Whitehead W E. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation.  Gastroenterology. 2005;  129 (1) 86-97
    Google Scholar
  • 86 Ford A C, Talley N J, Schoenfeld P S et al. Efficacy of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.  Gut. 2009;  58 (3) 367-378
    Google Scholar
  • 87 Peng H Y, Xu A Z. Colonic exclusion and combined therapy for refractory constipation.  World J Gastroenterol. 2006;  12 7864-7868
    Google Scholar
  • 88 Rink A D, Haaf F, Knupper N et al. Prospective randomised trial comparing ileocaecal interposition and colon-J-pouch as rectal replacement after total mesorectal excision.  Int J Colorectal Dis. 2007;  22 153-160
    Google Scholar
  • 89 Yoshioka K, Keighley M R. Randomized trial comparing anorectal myectomy and controlled anal dilatation for outlet obstruction.  Br J Surg. 1987;  74 1125-1129
    Google Scholar
  • 90 Renzi A, Talento P, Giardiello C et al. Stapled trans-anal rectal resection (STARR) by a new dedicated device for the surgical treatment of obstructed defaecation syndrome caused by rectal intussusception and rectocele: early results of a multicenter prospective study.  Int J Colorectal Dis. 2008;  23 999-1005
    Google Scholar
  • 91 Boccasanta P, Venturi M, Salamina G et al. New trends in the surgical treatment of outlet obstruction: clinical and functional results of two novel transanal stapled techniques from a randomised controlled trial.  Int J Colorectal Dis. 2004;  19 359-369
    Google Scholar
  • 92 Lehur P A, Stuto A, Fantoli M et al. Outcomes of stapled transanal rectal resection vs. biofeedback for the treatment of outlet obstruction associated with rectal intussusception and rectocele: a multicenter, randomized, controlled trial.  Dis Colon Rectum. 2008;  51 1611-1618
    Google Scholar
  • 93 Jarett M E, Mowatt G, Glazener C M et al. Systematic review of sacral nerve stimulation for fecal incontinence and constipation.  Br J Surg. 2004;  91 1559-1569
    Google Scholar
  • 94 Shafik A, Shafik A A, el-Sibai O et al. Colonic pacing in patients with constipation due to colonic inertia.  Med Sci Monit. 2003;  9 CR191-CR196
    Google Scholar
  • 95 Mowatt G, Glazener C, Jarrett M. Sacral nerve stimulation for faecal incontinence and constipation in adults.  Cochrane Database Syst Rev. 2007;  (3) CD004464
    Google Scholar
  • 96 Kamm M A, Dudding T C, Melenhorst J et al. Sacral nerve stimulation for intractable constipation.  Gut. 2010;  59 (3) 333-340
    Google Scholar
  • 97 Malone P S, Ransley P G, Kiely E M. Preliminary report: the antegrade continence enema.  Lancet. 1990;  336 1217-1218
    Google Scholar
  • 98 Hill J, Stott S, MacLennan I. Antegrade enemas for the treatment of severe idiopathic constipation.  Br J Surg. 1994;  81 1490-1491
    Google Scholar
  • 99 Hill J, Stott S, MacLennan I. Antegrade enemas for the treatment of severe idiopathic constipation.  Br J Surg. 1994;  81 1490-1491
    Google Scholar
  • 100 Rongen M J, Hoop A G, Baeten C G. Cecal access for antegrade colon enemas in medically refractory slow-transit constipation: a prospective study.  Dis Colon Rectum. 2001;  44 1644-1649
    Google Scholar
  • 101 Teichman J M, Zabihi van der N, Kraus S R et al. Long-term results for Malone antegrade continence enema for adults with neurogenic bowel disease.  Urology. 2003;  61 502-506
    Google Scholar
  • 102 Gerharz E W, Vik V, Webb G et al. The value of the MACE (malone antegrade colonic enema) Procedure in adult patients.  J Am Coll Surg. 1997;  185 544-547
    Google Scholar
  • 103 Portier G, Ghouti L, Kirzin S et al. Malone antegrade colonic irrigation: ileal neoappendicostomy is the preferred procedure in adults.  Int J Colorectal Dis. 2006;  21 (5) 458-460
    Google Scholar
  • 104 Pfeifer J. Surgery for constipation.  Acta Chir Iugosl. 2006;  53 (2) 71-79
    Google Scholar
  • 105 Ianelli A, Fabioni P, Mouiel J et al. Laparoscopic subtotal colectomy with ceceorectal anastomosis for slow-transit constipation.  Surg Endosc. 2006;  20 171-173
    Google Scholar
  • 106 Yoshioka K, Keighley M R. Clinical results of colectomy for severe constipation.  Br J Surg. 1989;  76 600-604
    Google Scholar
  • 107 Sarli L, Costi R, Sarli D et al. Pilot study of subtotal colectomy with antiperistaltic cecoproctostomy for the treatment of chronic slow-transit constipation.  Dis Colon Rectum. 2001;  44 (10) 1514-1520
    Google Scholar
  • 108 Marchesi F, Sarli L, Percalli L et al. Subtotal colectomy with antiperistaltic cecorectal anastomosis in the treatment of slow-transit constipation: long-term impact on quality of life.  World J Surg. 2007;  31 (8) 1658-1664
    Google Scholar
  • 109 Jiang C Q, Qian Q, Liu Z S et al. Subtotal colectomy with antiperistaltic cecoproctostomy for selected patients with slow transit constipation-from Chinese report.  Int J Colorectal Dis. 2008;  23 (12) 1251-1256
    Google Scholar
  • 110 Pomazkin V I. Antiperistaltic cecorectal anastomosis by subtotal colectomy.  Khirurgiia. 2009;  (7) 43-46
    Google Scholar
  • 111 Gladman M A, Scott S M, Chan C L et al. Rectal hyposensibility: prevalence and clinical impact in patients with intractable constipation and fecal incontinence.  Dis Colon Rectum. 2003;  46 238-246
    Google Scholar
  • 112 Pluta H, Bowes K L, Jewell L D. Long-term results of total abdominal colectomy for chronic idiopathic constipation. Value of preoperative assessment.  Dis Colon Rectum. 1996;  39 160-166
    Google Scholar
  • 113 Pikarsky A J, Singh J J, Weiss E G et al. Long-term follow-up in patients undergoing colectomy for colonic inertia.  Dis Colon Rectum. 2001;  44 179-183
    Google Scholar
  • 114 FitzHarris G P, Garcia-Aguilar J, Parker S C et al. Quality of life after subtotal colectomy for slow-transit constipation: both quality and quantity count.  Dis Colon Rectum. 2003;  46 433-440
    Google Scholar
  • 115 Sample C, Gupta R, Bamehriz F et al. Laparoscopic subtotal colectomy for colonic inertia.  J Gastrointest Surg. 2005;  9 803-808
    Google Scholar
  • 116 Pfeifer J, Agachan F, Wexner S D. Surgery for constipation: a review.  Dis Colon Rectum. 1996;  39 444-460
    Google Scholar
  • 117 DeGraaf Jr E, Gilberts L AM, Schouten W R. Role of colonic transit time studies to select patients with slow transit constipation for partial left-sided or subtotal colectomy.  Br J Surg. 1996;  83 648-651
    Google Scholar
  • 118 You Y T, Wang J Y, Changchien C R et al. Segmental colectomy in the management of colonic inertia.  Am Surg. 1998;  64 775-777
    Google Scholar
  • 119 Lundin E, Karlbom U, Pahlman L et al. Outcome of segmental colonic resection for slow-transit constipation.  Br J Surg. 2002;  89 1270-1274
    Google Scholar
  • 120 Ripetti V, Caputo D, Greco S et al. Is total colectomy the right choice in intractable slow-transit constipation?.  Surgery. 2006;  140 (3) 435-440
    Google Scholar
  • 121 Nicholls R J, Kamm M A. Proctocolectomy with restorative ileoanal reservoir for severe idiopathic constipation. Report of two cases.  Dis Colon Rectum. 1988;  31 968-699
    Google Scholar
  • 122 Hosie K B, Kmiot W A, Keighley M R. Constipation: another indication for restorative proctocolectomy.  Br J Surg. 1990;  77 801-802
    Google Scholar
  • 123 Stewart J, Kumar D, Keighley M R. Results of anal or low rectal anastomosis and pouch construction for megarectum and megacolon.  Br J Surg. 1994;  81 1051-1053
    Google Scholar
  • 124 Brown S R, Shorthouse A J. Restorative proctocolectomy for idiopathic megarectum: postoperative recovery of hypotonic anal sphincters. Report of two cases.  Dis Colon Rectum. 1997;  40 625-627
    Google Scholar
  • 125 O’Sulleabhain C B, Anderson J H, McKee R F et al. Strategy for the surgical management of patients with idiopathic megarectum and megacolon.  Br J Surg. 2001;  88 1392-1396
    Google Scholar
  • 126 Redmond J M, Smith G W, Barofsky I et al. Physiological tests to predict long term outcome of total abdominal colectomy for intractable constipation.  Am J Gastroenterol. 1995;  90 748-753
    Google Scholar
  • 127 Dippolito A, Esser S, Reed 3 rd J. Anterior modification of Delorme procedure provides equivalent results to Delorme procedure in treatment of rectal outlet obstruction.  Curr Surg. 2005;  62 609-612
    Google Scholar
  • 128 Biviano I, Badiali D, Candeloro L et al. Abstraktband UEGW. Wien; 2008: P0823
    Google Scholar
  • 129 Nyam D C, Pemberton J H, Ilstrup D M et al. Long-term results of surgery for chronic constipation.  Dis Colon Rectum. 1997;  40 (3) 273-279
    Google Scholar

1 Arbeitsgruppe Funktionsdiagnostik und Psychosomatik der ÖGGH: Heinz Hammer, Johann Hammer, Antje Holzäpfel, Andreas Mayer, Gabriele Moser, Gabriele Novi, Reingard Platzer, Johann Pfeifer, Harald Vogelsang, Peter Weiss, Max Wunderlich.

Prof. Dr. Gabriele Moser

Gastroenterologie und Hepatologie, Univ. Klinik für Innere Medizin III

Währinger Gürtel 18 – 20

1070 Wien

Österreich

Phone: ++ 43/1/4 04 00 47 41

Fax: ++ 43/1/4 04 00 47 35

Email: gabriele.moser@meduniwien.ac.at

      >